













The epidemiologic transition is marked 
by major changes in patterns of morbid-
ity and mortality [1]. For the longest time, 
malnutrition and infectious diseases were 
the main threats to human health and so-
ciety. Comparatively recently, improved 
living conditions and breakthrough ad-
vances in infectious disease control were 
followed by large increases in average life 
expectancy and the emergence of chronic 
health conditions. In industrialized coun-
tries cardiovascular disease became the 
leading cause of morbidity and mortali-
ty by the middle of the past century. Since 
then, life expectancy, disease patterns, and 
major causes of death have undergone 
further albeit less dramatic changes and 
these changes are closely tied to econom-
ic and social conditions [1, 2]. In affluent 
societies like Germany, longevity to very 
old age has shifted the disease spectrum to 
delayed degenerative diseases and to the 
coexistence of multiple health problems, 
also referred to as multimorbidity [3]. Co-
morbidity is often used interchangeably 
but more specifically relates to the pres-
ence of additional morbidities in relation 
to a given index disease [4].
Multi- and comorbidity have high 
public health relevance in aging popula-
tions [5]. Older persons are likely to suf-
fer from one or more diseases, age-related 
functional impairments, systemic chang-
es of the immune system, the endocrine 
system, and the ability to maintain salt 
and water balance as well as an increase 
in the use of psychotropic drugs [6, 7, 8, 9, 
10]. Not surprisingly, an increasing num-
ber of coexisting health conditions among 
older persons is associated with disabili-
ty, poorer health outcomes and quali-
ty of life, and higher health care utiliza-
tion [2, 5, 11, 12]. Health care systems need 
to adapt to the challenges of age-related 
changes in health problems and associ-
ated health care needs [2, 13, 14, 15]. For 
this, population-based data on common 
patterns of chronic health conditions are 
needed. Therefore, assessment of morbid-
ity in the population requires a shift from 
individual health conditions to comor-
bidity. Using data from the German tele-
phone health interview survey “German 
Health Update (GEDA)  2009”, we de-
termined the prevalence and patterns of 
chronic health conditions among adults 
in Germany in a population-based cross-
sectional study.
Methods
As part of the continuous national health 
monitoring, the Robert Koch Institute 
regularly conducts telephone health in-
terview surveys in representative sam-
ples of the German adult population 
(German Health Update, GEDA) [16]. 
These cross-sectional studies comple-
ment other cross-sectional and longitu-
dinal health interview and examination 
studies such as the German Health Inter-
view and Examination Surveys for Adults 
(DEGS, http://www.rki.de/degs), and the 
German Health Interview and Examina-
tion Survey for Children and Adolescents 
(KiGGS) [17].
Study design and study population
GEDA 2009 was funded by the German 
Federal Ministry of Health and carried out 
between July 2008 and June 2009. During 
that time, a total of 21,262 participants 
were interviewed by specifically trained 
interviewers who were closely supervised 
according to guidelines from the Behav-
ioral Risk Factor Surveillance System of 










tion [18], using a highly standardized pro-
tocol. The target population consisted of 
adults 18 years of age and older who were 
living in private households with landline 
telephones and could fluently speak Ger-
man. In a two-stage sampling procedure, 
sampling at the household level was per-
formed by a random digit dialling meth-
od [19] and the last-birthday method was 
applied for sampling at the individual lev-
el [20]. A total of 140–236 questions (de-
pending on age, sex, and the number of 
reported conditions) covered a range 
of health topics and health-related vari-
ables, including medical history and cur-
rent body weight and height for calcula-
tion of body mass index (BMI) estimates, 
and sociodemographic variables. Specifi-
cally, information was collected on a total 
of 22 health conditions (18 medical diag-
noses, 3 health problems, BMI) that com-
monly take a chronic or recurrent course 
and that can be expected to have a prev-
alence of at least 2% in the adult popula-
tion in Germany. Overall 53.2% of eligible 
individuals completed a computer-assist-
ed telephone interview (CATI). The study 
was approved by the federal and local of-
fice for data protection. All participants 




The mean interview duration was 31 min. 
Covering a list of 18 medical diagnoses, 
participants were asked whether a physi-
cian had ever told them that they had the 
disease and whether it had been present 
within the past 12 months. Lifetime prev-
alence estimates were determined for di-
agnoses which commonly represent ir-
reversible organ damage or underly-
ing chronic progressive disease process-
es (stroke, myocardial infarction (MI) or 
other coronary heart disease, any type of 
malignant disease). For all other diseas-
es (hypertension, hyperlipidemia, diabe-
tes mellitus, chronic heart failure, asth-
ma, chronic bronchitis, chronic renal dis-
ease, chronic liver disease, gastritis/duo-
denitis, gastric/duodenal ulcer, osteoar-
thritis, rheumatoid arthritis, osteoporo-
sis, depression), prevalence estimates rep-
resent the 12-month prevalence, in order 
to assure capturing of current health prob-
lems. Regarding a definition of hyperten-
sion and hyperlipidemia, information on 
current medication use was also obtained 
and considered. Questions regarding a 
history of osteoporosis were limited to 
study participants 50 years of age and old-
er. In addition, three symptomatic health 
problems were assessed. These includ-
ed self-reported chronic back pain for at 
least 3 months within the 12 months pre-




















  Women Men All
  (n) (%a) (n) (%a) (n) (%a)
Five age groups (years)
18–29 1,956 16.2 1,833 18.6 3,789 17.3
30–49 4,867 34.7 3,451 37.5 8,318 36.0
50–64 2,961 21.8 2,158 23.0 5,119 22.4
65–74 1,592 17.1 1,224 14.8 2,816 16.0
75 and older 738 10.2 482 6.1 1,220 8.2
Two age groups (years)
18–49 6,823 50.8 5,282 56.1 9,148 53.4
50 and older 5,291 49.2 3,864 43.9 12,114 46.6
All 12,114 51.5 9,148 48.5 21,262 100.0
Socio-economicstatusb (n) (%) (n) (%) (n) (%)
Low 1,475 22.5 910 17.4 2,385 20.0
Middle 7,174 60.9 4,775 59.0 11,916 60.0











































aWeighted estimates to represent the German population; bMissing data for 94 participants (0.4%), proportions 
refer to participants with complete information; cValues are adjusted for age; CI confidence interval.
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ed severe hearing and vision impairment 
as assessed in the European Heath Inter-
view Survey (EHIS) [21]. Finally, current 
BMI was calculated based on self-report-
ed height and weight. Obesity was defined 
as a BMI ≥ 30 kg/m2 [22].
Socioeconomic status (SES) was classi-
fied as low, middle, or high based on ed-
ucational and professional status and the 
net household income adjusted for house-
hold size [23].
The 22 health problems assessed were 
grouped into 9 disease categories as de-
fined by organ systems or disease enti-
ties as shown in . Tab. 1. Multimorbid-
ity was defined as the presence of two or 
more concurrent health conditions in one 
person and quantified by adding up the 
numbers of coexisting individual condi-
tions per person (morbidity count). Co-
morbidity was defined on the basis of dis-
ease categories as having health condi-
tions in one or more disease categories in 
addition to health problems in an index 
disease category. For estimates at the lev-
el of disease categories, persons with more 
than one health condition within the same 
disease category were counted only once 
unless stated otherwise.
Statistical analysis
We calculated the age- and sex-specific 
prevalence rates and 95% confidence in-
tervals for individual health conditions as 
well as for disease categories. For analysis 
of comorbidity patterns, all possible com-
binations of comorbidity dyads and triads 
were calculated. Combinations reaching 
a prevalence of at least 5% for comorbidi-
ty dyads and at least 2.5% for comorbidi-
ty triads are reported here. For age specif-
ic analyses, five age groups were defined: 
18–29, 30–49, 50–64, 65–74, ≥ 75 years. 
Analyses of comorbidity patterns were re-
stricted to comparisons between young-
er and older adults using a cut-off of 50 
years of age (< 50 vs. ≥ 50 years). In or-
der to represent the adult residential pop-
ulation of Germany, data were weighted 
to adjust for sampling design and non-
response. Analyses were conducted us-
ing PASW Statistics (version 18.0.3, SPSS 
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Characteristics of the study population 
are presented in . Tab. 2. The study pop-
ulation consisted of 21,262 community-
dwelling residents (51.5% women, 48.5% 
men) aged between 18 and 100 years. 
Mean age was 50.1 years for women 
and 47.6 years for men. A total of 24.2% 
(27.4% of women, 20.9% of men) were 
65 years and older.
Overall, the single most prevalent 
health condition among both sexes was 
hypertension (women 26.3%, men 25.6%). 
Among men and women, further ranking 
of the five most frequent health problems 
included the same conditions but their 
order slightly differed: hyperlipidemia, 
chronic back pain, obesity, and osteo-
arthritis. Coronary heart disease (CHD) 
with or without myocardial infarction 
(MI) was the sixth most prevalent condi-
tion in men at 9.2% (women 6.5%). The 
sixth most prevalent condition in wom-
en was osteoporosis at 15.1%, which was 
of minor importance among men (4.4%). 
Lifetime prevalence for any malignant 
disease was 8.4% for women and 5.3% for 
men. A diagnosis of depression within the 
12 months preceding the interview was 
reported by 8.0% of women and 4.5% of 
men. Overall, 5.9% of women and 4.8% of 
men had a history of asthma. Health con-
ditions with an overall prevalence of less 
than 2% included chronic renal and liv-
er disease in both sexes, and hearing im-
pairment among men. Detailed informa-
tion on the age- and sex-specific preva-
lence of individual health conditions and 
disease categories is provided in supple-
mental . Tab. 1 and . Tab. 2.
The five leading morbidities among 
young women and men (18–29 years) in-
cluded chronic back pain, obesity, asth-
ma, and depression as well as gastri-
tis/duodenitis among women and hy-
pertension among men. Among older 
adults, hypertension and hyperlipidemia 
ranked among the five leading morbidi-
ties in both sexes, along with osteoarthri-
tis, chronic back pain, obesity, and in men 
and women of the oldest age groups, coro-
nary heart disease.
The prevalence of sensory limitations, 
coronary heart disease, stroke as well as 
cancer among men and hypertension, 
heart failure, osteoporosis, and rheuma-
toid arthritis among women significant-
ly and continuously rose with increasing 
age. Other chronic conditions, including 
hyperlipidemia, obesity, diabetes melli-
tus, osteoarthritis, and chronic back pain 
showed a significant and positive increase 
in prevalence with age up to age group 65–
74 years and a leveling thereafter. No sig-
nificant association with age in either sex 
was observed for asthma, chronic bron-
chitis, depression, or upper gastric, chron-
ic renal or chronic liver disease. Below age 
50 years, women had significantly less hy-
pertension and significantly more osteo-
arthritis, chronic back pain, and depres-
sion than men, while sex differences in 
older persons were characterized by sig-
nificantly higher prevalence of all muscu-
1 2 3 4 5 and morenone
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loskeletal conditions, hypertension, and 
hyperlipidemia and (up to age 75 years) 
lower prevalence of cardiovascular disease 
in women compared to men. Between age 
30 and 74 years, women were also signifi-
cantly more likely to have a history of ma-
lignant disease than men. This was par-
ticularly true for coronary heart disease, 
stroke, osteoporosis, and sensory limita-
tions.
The number of coexistent health con-
ditions ranged from 0–16. The median in-
creased with age from 0 among partici-
pants 18–29 years old to 4 among women 
and 3 among men 75 years and older. The 
mean number of coexistent health con-
ditions was significantly higher in wom-
en (1.89) than in men (1.52; p = 0.000). 
The age-adjusted comparison of means 
showed significant sex-differences in all 
age-groups except in the age group 30–
49 years of age.
Overall, 43.9% of women and 36.3% of 
men had two or more chronic conditions. 
The prevalence and magnitude of multi-
morbidity increased with age in both sex-
es, particularly among persons 50 years of 
age and older (. Fig. 1). Specifically, the 
prevalence of five or more health condi-
tions rose from 1–2% in the two young-
est age groups to 12–13% among men and 
women 50–64 years of age to 20% among 
men and 30% among women 65–74 years 
of age, and to more than 25% among 
men and more than 34% among women 
75 years and older.
The age- and sex-specific prevalence 
estimates based on disease categories are 
summarized in . Fig. 2. In both sexes, a 
steady increase across age groups was ev-
ident for cardiovascular disease, chronic 
renal, or liver disease and in men muscu-
loskeletal disease and cancer. This was al-
so true for cardiometabolic conditions in 
women, although obesity and hyperlipid-
emia showed no further increase among 
persons in the oldest age group (supple-
mental . Tab. 1 and . Tab. 2). The prev-
alence of persons with any severe sensory 
limitation gradually increased from 1–2% 
among persons 18–29 years of age to 8–9% 
among those in the age group 65–74 years. 
It then steeply rose to 20.8% among wom-
en and 14.8% among men aged 75 years 
and older. No age-related increase in prev-
alence was observed for diseases of the 
lower respiratory or upper gastrointesti-
nal tract or for depression, which showed 
a peak in middle age among both sex-
es (. Fig. 2, supplemental . Tab. 1 and 
. Tab. 2).
Prevalence rates and proportions of 
persons with additional comorbidities ac-
cording to specific index disease categories 
by sex and age strata (< 50 vs. ≥ 50 years) 
are summarized in . Fig. 3. The propor-
tions of persons with and without addi-
tional comorbidities below age 50 years 
was below 5% for all conditions except for 
cardiometabolic, musculoskeletal, and 
lower respiratory conditions in both sexes 
and depression in women (. Fig. 3a). In 
comparison, the prevalence of health con-
ditions as well as the proportion of per-
sons with additional comorbidities was 
generally higher among men and wom-
en 50 years and older. For example, the 
prevalence of cardiometabolic conditions 
with comorbidities in two or more other 
disease categories increased from 4.3% in 
women and 3.0% in men below 50 years of 
age to 28.9% in women and 23.1% in men 
aged 50 years and older (. Fig. 3). The 
majority of older men and women with 
sensory limitations, depression, chronic 
liver or renal disease, chronic respiratory 
disease, or upper gastric disease had addi-
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The sex-specific prevalence of the 
most common combinations of comor-
bidity patterns is reported by age strata in 
. Tab. 3. Among persons up to 50 years 
of age, only a combination of cardiometa-
bolic conditions and musculoskeletal dis-
eases occurred at a prevalence exceeding 
5% (women 6.9%, men 5.6%). Among 
men and women 50 years and older, this 
particular comorbidity dyad was present 
in 41.6% of women and 27.6% of men. 
Less frequent combinations were ob-
served for 11 other comorbidity dyads in-
cluding combinations of cardiometabol-
ic conditions and cardiovascular disease 
(women 15.3%, men 19.6%), and of car-
diometabolic conditions and depression 
(women 10.3%, men 7.3%). With respect 
to comorbidity triads, we found 11 com-
binations exceeding a prevalence of 2.5% 
among older persons as compared to no 
such combinations in the younger pop-
ulation. The most frequent comorbidity 
triads were combinations of cardiometa-
bolic, cardiovascular, and musculoskele-
tal conditions (women 11.5%, men 9.5%), 
of cardiometabolic conditions, lower re-
spiratory, and musculoskeletal disease 
(women 6.7%, men 3.7%), and of car-
diometabolic conditions, musculoskele-
tal disease, and depression (women 6.7%, 
men 3.3%).
Discussion
The present study describes prevalences 
and patterns of morbidity and comorbidi-
ty among German adults 18 years and old-
er. The single most prevalent health con-
ditions among both sexes were hyperten-
sion, hyperlipidemia, chronic back pain, 
obesity, and osteoarthritis. They main-
ly showed a significant increase in preva-
lence with age up to age group 65–74 years 
and a leveling thereafter.
The prevalence of multimorbidity de-
fined as two or more coexisting chronic 
health conditions increased similarly with 
age in both sexes. Above age 50 years, half 
of men and almost two-thirds of wom-
en had comorbidities in two or more dis-
ease categories. The most prevalent dis-
ease category dyads and triads included 
combinations between cardiometabolic 
conditions, cardiovascular, and musculo-
skeletal disease, followed by combinations 
with depression, sensory limitations, and 
cancer. Patterns of morbidity and multi-
morbidity were similar in both sexes, but 
multi- and comorbidity was more preva-




Comparisons of results on conditions be-
tween studies are limited because of con-
siderable differences in data sources, time 
trends, age range, recruitment of study 
populations, study period, number and 
assessment of conditions, and definitions 
as far as cut-offs of blood pressure and se-
rum lipid measurements. For the compar-
ison of our results with those from other 
studies, we used data from German sur-
veys as far as possible. With respect to in-
dividual health conditions, comparisons 
will focus on the highly prevalent condi-
tions hypertension, chronic back pain, os-
teoarthritis, hyperlipidemia, obesity, and 
in women, osteoporosis.
In the present study, the prevalence 
of self-reported physician-diagnosed hy-
pertension within the past 12-months or 
current antihypertensive treatment was 
26.3% among women and 25.6% among 
men. These prevalence estimates are con-
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1998 German National Health Interview 
and Examination Survey (GNHIES 1998) 
that were based on standardized blood 
pressure measurements using cut-offs 
of 140 mmHg/90 mmHg [24]. The prev-
alence of hypertension based on blood 
pressure measurements in other German 
studies ranged from 28.6–38.5% for wom-
en, and from 41.4–60.1% for men [25]. 
Similarly, in GNHIES 34.9% of women 
and 32.2% of men had serum cholester-
ol levels exceeding 250 mg/100 ml [24] as 
compared to 21.8% of women and 19.8% 
of men reporting a medical history of hy-
perlipidemia within the past 12 months or 
current use of lipid lowering in the present 
study. It is obvious that estimates based on 
self-report with or without consideration 
of medication use are likely to under-
estimate the prevalence of hyperlipid-
emia and hypertension due to underdi-
agnosis. In addition, some of the differ-
ences compared to previous studies may 
be due to changes in prevalence rates over 
time. However, focusing on the popula-
tion 65 years and older, our prevalence es-
timates are similar to those observed in a 
recent analysis of claims data from a large 
German sickness fund [26] and results 
from previous German telephone health 
interview surveys [27].
It is well known that people tend to 
under estimate their weight and over-
estimate their height, which leads to low-
er prevalence of overweight and obesi-
ty in studies based on self-reported data 
compared to studies in which height and 
weight were measured [28]. It is, there-
fore, likely that our prevalence estimates 
of obesity are underestimated as well. 
However, obesity prevalence estimates de-
rived from our study (women 15.7%, men 
16.3%) are approaching the results of the 
most recent German microcensus survey 
which are also based on self-report (wom-
en 13.8%, men 15.7%) [29].
In the telephone health survey 2003 
(GSTel03), 21.6% of women and 15.5% 
of men reported to suffer from chronic 
back pain [30]. Estimates observed in the 
present study are slightly higher (wom-
en 24.5%, men 16.6%), possibly due to the 
higher mean age of the GEDA09 popula-
tion compared to the GSTel03 population.
In GEDA09, 23.1% of women and 
13.7% of men had osteoarthritis. Simi-
lar prevalence estimates were observed in 
the GSTel03 survey (women 23.2%, men 
15.9%).
Lifetime prevalence of osteoporosis in 
GSTel03 was 14.2% among women aged 
45 and older, rising from 3.4% for the age 
group 45–54 to 23.7% in the age group 
75 and older [31]. Data for men were not 
available in this previous survey. The 
Augsburg MONICA study which includ-
ed persons aged 25–74 reported an overall 
lifetime prevalence of 7% in women and 
1% in men [25]. In the present study, the 
12-month prevalence of osteoporosis was 
assessed in persons aged 50 years and old-




As there is no agreed gold standard to as-
sess multimorbidity, results are likely to 
differ between studies due to method-
ological issues. Differences relate to the 
definition of multimorbidity, the num-
ber and types of included health condi-
tions, and the method of data collection 
(e.g., information based on self-report or 
abstracted from claims data). There is ev-
idence that the prevalence of multimor-
bidity is substantially lower when estimat-
ed in a general population compared to 
the primary care setting [32]. In Germa-



























Any severe sensory limitation
Cancer







Any severe sensory limitation
Cancer




with comorb. in two and more areas








ny, these differences are probably smaller 
due to the overall high utilization of am-
bulatory medical care [33]. For these rea-
sons, study results are not directly compa-
rable [11, 34].
A recent review found that prevalence 
of multimorbidity (defined as two or 
more concurrent diseases) in older per-
sons ranged from 55–98% [5]. In a recent 
British retrospective cohort study using 
the Johns Hopkins University Adjust-
ed Clinical Groups (ACG(R)) Case-Mix 
System based on combinations of condi-
tions occurring in individuals [35], 58% 
had multimorbidity [36]. Another study 
in Ireland found a prevalence of 66.2% in 
patients over 50 years of age [37]. In a re-
cent German study based on claims da-
ta, 62% of persons aged 65 and older had 
multimorbidity defined as at least 3 diag-
noses out of a list of 46 chronic conditions 
[38], as compared to 74.6% of participants 
65 years and older in the present analysis. 
Most of the recent German epidemiologi-
cal studies show an increase of multimor-
bidity with age but prevalence estimates 
differ considerably [2, 26, 38].
While multimorbidity is increasing-
ly recognized as a public health problem 
of aging societies, the distribution and 
combination of concurrent health con-
ditions still does not receive sufficient 
attention [5]. In Germany, the GSTel03 
already demonstrated the high preva-
lence of multimorbidity and the impor-
tance of a combined analysis of condi-
tions. In this previous survey of adults 
18 years and older, a total of 16 condi-
tions were grouped into 10 disease cate-
gories. Overall, 16.8% of the respondents 
did not report any of the included condi-
tions, 56.4% reported conditions in one 
or two, 22.4% in three and 4.5% in four or 
more disease categories with an increase 
by age groups [39]. In a recent German 
study based on claims data, the authors 
used different criteria to define disease 
categories; however, morbidity patterns 
were similar to those observed in the 
present study [38].
Strengths and limitations
The assessment of 22 different conditions 
in more than 21,000 participants facili-
tates the analysis of multimorbidity. Nev-
ertheless analyses are limited due to small 
numbers within some age- and sex-specif-
ic groups. We focused on prevalent health 
conditions, hence less prevalent but severe 
chronic diseases, such as multiple sclero-
sis or Parkinson’s disease were not includ-
ed in the survey questionnaire interview.
Only community-dwelling people with 
at most light cognitive impairments and 
who were able to take part in the Ger-
man-language interview participated in 
the study. Persons with dementia, severe-
ly ill or limited persons who were hospi-
talized or living in institutions (e.g., nurs-
ing home residents) with a possible high-
er burden of disease were not included in 
our study.
In our study, the mean number of co-
existent health conditions was signifi-
cantly higher in women than men. Sever-
al previous studies have reported sex dif-
ferences in the prevalence of chronic con-
ditions that are in line with our results 
[40, 41, 42]. A recent publication compar-
ing the prevalence of chronic conditions 
in different countries found that women 
were more likely to report arthritis and 
depression, whereas men were more like-
ly to report diseases of the heart [43]. In a 
German study based on claims data, men 
had a higher prevalence of coronary ar-
tery disease than women across all age 
groups. A higher prevalence of heart fail-
ure and hypertension among women than 
men was restricted to higher age groups 
[44]. There is evidence that women do 
not simply over-report morbidity [45, 46]. 
Our study underlines the importance of 
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considering and reporting sex and gender 
differences in morbidity.
Relying on self-reported medical di-
agnoses remains a problem as this bears 
the potential of over- and underreporting, 
leading to misclassification. We tried to 
minimize false positive answers by asking 
for a diagnosis given by a physician. Self-
reported diagnoses as used in GEDA may 
underestimate prevalence due to limited 
knowledge of the participants. However, 
there is evidence that the method is an ef-
ficient way to estimate disease prevalence 
in epidemiological studies with good va-
lidity for some and less validity for other 
conditions [47, 48]. Validation by physi-
cian records was beyond the scope of this 
study; in addition, medical records have 
their own limitations [49].
Practical implications
The results of our study underline the 
importance of a broad view on health 
and illness. Persons with multiple con-
ditions may need more careful and syn-
chronized assessment, diagnosis, and 
treatment. The co-occurrence of condi-
tions in different categories has implica-
tions, for example, for prescribing med-
ication (awareness of polypharmacy and 
potential drug interaction as well as pre-
scribing omissions) and setting priorities 
in treatment [50, 51].
Furthermore, the existence of differ-
ent diseases and conditions are of great 
importance for epidemiological research. 
Research paradigms have to move from 
examining comorbidities to reveal com-
prehensive disease or condition group-
ings.
In cross-sectional studies such as ours, 
only associations between condition 
groups can be examined, but no causal 






























X         X       6.9 (6.1–7.7) 5.6 (4.8–6.5))
People 50 and older
X         X       41.6 (39.8–
43.5)
27.6 25.8–29.5)




  X       X       12.6 (11.3–
14.0)
10.9 (9.7–12.3)
X             X   10.3 (9.2–
11.6)
7.3 (6.3–8.4)
          X   X   8.6 (7.6–9.7) 4.5 (3.8–5.4)
X   X             8.5 (7.5–9.7) 7.1 (6.1–8.3)
    X     X       7.7 (6.8–8.8) 4.9 (4.0–5.9)
X               X 7.4 (6.4–8.5) 5.9 (4.9–7.0)
          X     X 6.8 (5.8–7.9) 5.0 (4.2–6.1)
          X X     6.5 (5.7–7.5) 3.6 (2.8–4.5)
X           X     6.3 (5.5–7.3) 4.4 (3.6–5.3)




X X       X       11.5 (10.3–
12.9)
9.5 (8.4–10.9)
X   X     X       6.7 (5.8–7.7) 3.7 (3.0–4.6)
X         X   X   6.7 (5.8–7.8) 3.3 (2.6–4.0)
X         X     X 5.3 (4.4–6.3) 4.1 (3.3–5.1)
X         X X     5.1 (4.3–6.0) 2.8 (2.2–3.6)
X       X X       4.1 (3.4–4.9) 2.4 (1.8–3.1)
X     X   X       3.8 (3.1–4.8) 2.0 (1.5–2.7)
X X X             3.3 (2.7–4.1) 2.8 (2.2–3.6)
X X             X 2.9 (2.3–3.7) 2.2 (1.6–3.0)
  X X     X       2.9 (2.3–3.6) 1.6 (1.1–2.2)
  X       X     X 2.5 (2.0–3.3) 1.8 (1.3–2.5)
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causes and symptoms, longitudinal de-
signs are necessary.
To date there is no gold standard for 
collecting or analyzing morbidity pat-
terns, although some valuable approach-
es exist [48, 52]. In order to assure com-
parability of study results between stud-
ies and over time, research needs to take 
on the task of developing evidence-based 
consensus criteria on which conditions 
should be included in epidemiological 
studies and how they should be catego-
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